Want to take quizzes and track your credits?
National estimates project COVID-19 negatively influenced cancer screening, leading to an estimated deficit of 3.9 million breast cancer (BC) screenings among US adults.1,2 In San Francisco, California, low-income neighborhoods disproportionately affected by COVID-19 bear the burden of higher BC stage at diagnosis.3,4 We sought to evaluate the association of COVID-19 and BC screening in a safety-net hospital in San Francisco.
Sign in to take quiz and track your certificates
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: June 3, 2021.
Published: August 6, 2021. doi:10.1001/jamanetworkopen.2021.19929
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Velazquez AI et al. JAMA Network Open.
Corresponding Author: Ana I. Velazquez, MD, MSc, National Clinician Scholars Program, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, 290 Illinois St, Ste 7227, Box 0936, San Francisco, CA 94158 (firstname.lastname@example.org).
Author Contributions: Drs Velazquez and Dixit had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Velazquez, Gregory, Dixit.
Acquisition, analysis, or interpretation of data: Velazquez, Hayward, Dixit.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Velazquez, Gregory.
Obtained funding: Dixit.
Administrative, technical, or material support: Dixit.
Supervision: Hayward, Dixit.
Conflict of Interest Disclosures: Dr Velazquez reported receiving travel funds from the American Society of Clinical Oncology outside the submitted work, and that an immediate family member is a former employee of Johnson & Johnson Innovation and has stock ownership in Portola Pharmaceuticals, Corbus Pharmaceuticals, and Midatech. Dr Dixit reported financial compensation from Bristol Myers Squibb for participation in an advisory board outside the submitted work. No other disclosures were reported.
Funding/Support: This research was funded by the University of California, San Francisco (UCSF), Helen Diller Comprehensive Cancer Center at UCSF through the San Francisco Cancer Initiative. Dr Velazquez is supported by the UCSF National Clinician Scholars Program and by the National Institute on Aging of the National Institutes of Health (NIH) under award P30AG015272.
Role of the Funder/Sponsor: The Helen Diller Comprehensive Cancer Center had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
You currently have no searches saved.
You currently have no courses saved.